Evaluation of the therapeutic efficiency of the placenta mesenchymal stem cell–derived exosomes on improvement of lung disease symptoms
Not Applicable
- Conditions
- Systemic sclerosis (scleroderma).Systemic sclerosis [scleroderma]
- Registration Number
- IRCT20130812014333N224
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Definitive diagnosis of systemic sclerosis
Interstitial lung disease confirmed by chest CT scan and pulmonary function tests
Informed consent
Exclusion Criteria
Suffering from other autoimmune diseases
Uncontrolled high blood pressure
Diabetes and other endocrine disorders
Cardiovascular failure
Chronic kidney failure
Liver dysfunction
Depression
The presence of life-threatening complications including severe hemolysis of platelets below 40,000
Pregnancy and breastfeeding
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method